80 related articles for article (PubMed ID: 1299978)
1. [Pulmonary toxicity of nilutamide (Anandron). Cooperative evaluation of French Regional Pharmacovigilance Centers].
Jonville AP; Diot E; Dutertre JP; Autret E
Therapie; 1992; 47(5):393-7. PubMed ID: 1299978
[TBL] [Abstract][Full Text] [Related]
2. [Fatal fulminant hepatitis induced by nilutamide (Anandron)].
Pescatore P; Hammel P; Durand F; Bertheau P; Bernuau J; Huc D; Gerbal JL; Degott C; Benhamou JP
Gastroenterol Clin Biol; 1993; 17(6-7):499-501. PubMed ID: 8243938
[TBL] [Abstract][Full Text] [Related]
3. Anandron (RU 23908) in metastatic prostate cancer: preliminary results of a multicentric Italian study.
Boccardo F; Decensi AU; Guarneri D; Martorana G; Fioretto L; Mini E; Macaluso MP; Giuliani L; Santi L; Periti P
Cancer Detect Prev; 1991; 15(6):501-3. PubMed ID: 1782640
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous liver and lung toxicity related to the nonsteroidal antiandrogen nilutamide (Anandron): a case report.
Gomez JL; Dupont A; Cusan L; Tremblay M; Tremblay M; Labrie F
Am J Med; 1992 May; 92(5):563-6. PubMed ID: 1580304
[TBL] [Abstract][Full Text] [Related]
5. Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails.
Kassouf W; Tanguay S; Aprikian AG
J Urol; 2003 May; 169(5):1742-4. PubMed ID: 12686822
[TBL] [Abstract][Full Text] [Related]
6. Antiandrogen withdrawal syndrome with nilutamide.
Gomella LG; Ismail M; Nathan FE
J Urol; 1997 Apr; 157(4):1366. PubMed ID: 9120950
[No Abstract] [Full Text] [Related]
7. [Fatal fulminating hepatitis caused by nilutamide. A new case].
Marty F; Godart D; Doermann F; Mérillon H
Gastroenterol Clin Biol; 1996; 20(8-9):710-1. PubMed ID: 8977826
[No Abstract] [Full Text] [Related]
8. Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
Nakabayashi M; Regan MM; Lifsey D; Kantoff PW; Taplin ME; Sartor O; Oh WK
BJU Int; 2005 Oct; 96(6):783-6. PubMed ID: 16153200
[TBL] [Abstract][Full Text] [Related]
9. [Amiodarone-induced pleuropneumopathies: experience 1983-1993 in a drug vigilance Regional Center].
Graille V; Lapeyre-Mestre M; Montastruc JL
Therapie; 1994; 49(5):421-4. PubMed ID: 7855756
[TBL] [Abstract][Full Text] [Related]
10. Reduction of nilutamide by NO synthases: implications for the adverse effects of this nitroaromatic antiandrogen drug.
Ask K; Dijols S; Giroud C; Casse L; Frapart YM; Sari MA; Kim KS; Stuehr DJ; Mansuy D; Camus P; Boucher JL
Chem Res Toxicol; 2003 Dec; 16(12):1547-54. PubMed ID: 14680368
[TBL] [Abstract][Full Text] [Related]
11. [Clinical study of RU 23908 (nilutamide) in prostatic cancer].
Akaza H; Aso Y; Niijima T; Fuse H; Izaka S; Akimoto S; Shimazaki J; Imai K; Yamanaka H; Kihara K
Hinyokika Kiyo; 1991 Apr; 37(4):407-20. PubMed ID: 1892002
[TBL] [Abstract][Full Text] [Related]
12. Generation of free radicals during the reductive metabolism of nilutamide by lung microsomes: possible role in the development of lung lesions in patients treated with this anti-androgen.
Berger V; Berson A; Wolf C; Chachaty C; Fau D; Fromenty B; Pessayre D
Biochem Pharmacol; 1992 Feb; 43(3):654-7. PubMed ID: 1311586
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary complications of hormone treatment in prostate carcinoma.
Seigneur J; Trechot PF; Hubert J; Lamy P
Chest; 1988 May; 93(5):1106. PubMed ID: 3129240
[TBL] [Abstract][Full Text] [Related]
14. Nilutamide pneumonitis: a report on eight patients.
Pfitzenmeyer P; Foucher P; Piard F; Coudert B; Braud ML; Gabez P; Lacroix S; Mabille JP; Camus P
Thorax; 1992 Aug; 47(8):622-7. PubMed ID: 1412120
[TBL] [Abstract][Full Text] [Related]
15. Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo.
Brisset JM; Boccon-Gibod L; Botto H; Camey M; Cariou G; Duclos JM; Duval F; Gontiès D; Jorest R; Lamy L
Prog Clin Biol Res; 1987; 243A():411-22. PubMed ID: 3309973
[No Abstract] [Full Text] [Related]
16. [Fever caused by fipexide. Evaluation of the national pharmacovigilance survey].
Guy C; Blay N; Rousset H; Fardeau V; Ollagnier M
Therapie; 1990; 45(5):429-31. PubMed ID: 2260037
[TBL] [Abstract][Full Text] [Related]
17. A controlled trial of castration with and without nilutamide in metastatic prostatic carcinoma.
Béland G; Elhilali M; Fradet Y; Laroche B; Ramsey EW; Trachtenberg J; Venner PM; Tewari HD
Cancer; 1990 Sep; 66(5 Suppl):1074-9. PubMed ID: 2203517
[TBL] [Abstract][Full Text] [Related]
18. [Acute depressive syndrome possibly due to nilutamide (Anandron) treatment].
Maroy B; Pitrou P
Therapie; 1997; 52(1):79-81. PubMed ID: 9183930
[No Abstract] [Full Text] [Related]
19. ["Eosinophilia-myalgia" syndrome due to L-tryptophan containing products. Cooperative evaluation of French Regional Centers of Pharmacovigilance. Analysis of 24 cases].
Castot A; Bidault I; Bournerias I; Carlier P; Efthymiou ML
Therapie; 1991; 46(5):355-65. PubMed ID: 1754978
[TBL] [Abstract][Full Text] [Related]
20. Comment: clinical experiences of visual disturbances with nilutamide.
Dijkman GA; Klotz LH; Diokno AC; Zippe CD
Ann Pharmacother; 1997 Dec; 31(12):1550-2. PubMed ID: 9416403
[No Abstract] [Full Text] [Related]
[Next] [New Search]